Media coverage
11
Media coverage
Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet Morningstar.com Country/Territory United States Date 4/01/21 URL https://www.morningstar.com/news/globe-newswire/8119757/landos-biopharma-announces-positive-results-from-a-phase-2-trial-of-oral-bt-11-for-patients-with-ulcerative-colitis Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet TMC Net Country/Territory United States Date 4/01/21 URL www.tmcnet.com/usubmit/-landos-biopharma-announces-positive-results-from-phase-2-/2021/01/04/9282938.htm Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet Yahoo! Finance Country/Territory United States Date 4/01/21 URL https://finance.yahoo.com/news/landos-biopharma-announces-positive-results-120000305.html Persons Jean-Frédéric Colombel Title Positive Results from a Phase 2 Trial of Oral BT 11 for Patients with Ulcerative Colitis Media name/outlet Market News Publishing Country/Territory United States Date 4/01/21 Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet MarketScreener.com Country/Territory United States Date 4/01/21 URL https://www.marketscreener.com/news/latest/Landos-Biopharma-Announces-Positive-Results-from-a-Phase-2-Trial-of-Oral-BT-11-for-Patients-with-Ulc--32115298/ Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet Customer Zone 360.com Country/Territory United States Date 4/01/21 URL www.customerzone360.com/news/2021/01/04/9282938.htm Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet Jotup Country/Territory United States Date 4/01/21 URL https://jotup.co/node/1110598 Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet BioSpace Country/Territory United States Date 4/01/21 URL https://www.biospace.com/article/releases/landos-biopharma-announces-positive-results-from-a-phase-2-trial-of-oral-bt-11-for-patients-with-ulcerative-colitis/ Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet GlobeNewswire Country/Territory United States Date 4/01/21 URL www.globenewswire.com/news-release/2021/01/04/2152516/0/en/Landos-Biopharma-Announces-Positive-Results-from-a-Phase-2-Trial-of-Oral-BT-11-for-Patients-with-Ulcerative-Colitis.html Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 4/01/21 Persons Jean-Frédéric Colombel Title Landos Biopharma Announces Positive Results from a Phase 2 Trial of Oral BT-11 for Patients with Ulcerative Colitis Media name/outlet BizWire Express Country/Territory India Date 4/01/21 URL www.bizwireexpress.com/showstoryGNW.php?storyid=119429 Persons Jean-Frédéric Colombel